Comprehensive Financial Management LLC
Position in EIKN — Eikon Therapeutics, Inc.
CIK 1799802
Los Gatos, CA
Position in EIKN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,517,401
+$287,201 QoQ
Shares Held
116,276
0.0% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EIKN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Comprehensive Financial Management LLC holds $11,980,338 across 5 Biotechnology names. EIKN ranks #4 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NAUT |
Nautilus Biotechnology, Inc.
|
2,207,619 | $4,128,247 | |
| 2 | RXRX |
Recursion Pharmaceuticals, Inc.
|
941,895 | $3,456,754 | |
| 3 | TWST |
Twist Bioscience Corp
|
26,273 | $2,702,966 | |
| 4 | EIKN |
Eikon Therapeutics, Inc.
This page
|
116,276 | $1,517,401 | |
| 5 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
17,656 | $174,970 |
All Filings in EIKN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,517,401 | 116,276 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,230,200 | 116,276 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||